Evidence map›Paper›PMID 10085235›Full record

ArticleThe Biochemical journal1999

Characterization of beta2 (CD18) integrin phosphorylation in phorbol ester-activated T lymphocytes.

L Valmu, T J Hilden, G van Willigen, C G Gahmberg

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Regulation of integrin activity and signalling.Biochimica et biophysica acta · 2009
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Role of the cytoplasmic tyrosines of beta 1A integrins in transformation by v-src.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

L ValmuDepartment of Biosciences, Division of Biochemistry, P.O. Box 56 (Viikinkaari 5), 00014 University of Helsinki, Finland.
T J Hilden
G van Willigen
C G Gahmberg
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrins are transmembrane proteins involved in cell-cell and cell-extracellular-matrix interactions. The affinity and avidity of integrins for their ligands change in response to cytoplasmic signals. This 'inside-out' activation has been reported to occur also with beta2 integrins (CD18). The beta2 integrin subunit has previously been shown to become phosphorylated in T lymphocytes on cytoplasmic serine and the functionally important threonine residues after treatment with phorbol esters or on triggering of T-cell receptors. We have now characterized the phosphorylation of beta2 integrins in T-cells in more detail. When T-cells were activated by phorbol esters the phosphorylation was mainly on Ser756. After inhibition of serine/threonine phosphatases, phosphorylation was also found in two of the threonine residues in the threonine triplet 758-760 of the beta2 cytoplasmic domain. Activation of T-cells by phorbol esters resulted in phosphorylation in only approx. 10% of the integrin molecules. Okadaic acid increased this phosphorylation to approx. 30% of the beta2 molecules, assuming three phosphorylation sites. This indicates that a strong dynamic phosphorylation exists in serine and threonine residues of the beta2 integrins.

Indexed as

Amino Acid SequenceCD18 AntigensElectrophoresis, Polyacrylamide GelHumansLymphocyte ActivationMolecular Sequence DataPeptide MappingPhosphorylationTetradecanoylphorbol AcetateT-LymphocytesCD18 AntigensTetradecanoylphorbol Acetate

Identifiers

PMID10085235
PMCPMC1220135
OpenAlexW1993997506

What OpenQuestion holds

Texttitle and abstract
measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.